Latest Period
Q1 2026
Security Snapshot
Enveric Biosciences, Inc. - Common Stock, $0.01 par value (ENVB) Institutional Ownership
CUSIP: 29405E505
13F Institutional Holders and Ownership History from Q4 2025 to Q1 2026
Institutions Reporting
11
Shares (Excl. Options)
54,976
Price
$1.94
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
- Security type / class
- Equity / Common Stock, $0.01 par value
- Symbol
- ENVB on Nasdaq
- Shares outstanding
- 2,048,691
- Reported price per share
- $2.85
- All holders as of 31 Mar 2026
- Q1 2026
- Total 13F shares
- 54,976
- Total reported value
- $106,594
- Portfolio coverage rank
- 0%
- Share change
- +30,805
- Value change
- +$55,846
- Number of holders
- 11
Security identity
Issuer context
Latest holder snapshot
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Key facts
- ENVB - Enveric Biosciences, Inc. - Common Stock, $0.01 par value is tracked under CUSIP 29405E505.
- 11 institutions reported positions in Q1 2026.
- 3 significant owners is listed from Schedule 13D/13G reporting.
Change
- Holder count moved from 11 to 11 between Q4 2025 and Q1 2026.
- Reported value moved from $87,744 to $106,594.
Research use
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Evidence
Source: SEC Form 13F
Open SEC Evidence
Latest holder context comes from 11 institutions filings for Q1 2026.
Security key
29405E505
Latest holder period
Q1 2026
13F holders
11
13D/G owners
3
CIK / CUSIP context first
Open Q1 2026 holders
ENVB full holder history
Enveric Biosciences, Inc. SEC filings
Enveric Biosciences, Inc. company facts
Enveric Biosciences, Inc. insider transactions
Broader feeds
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 29405E505:
13D/G owners
Significant owners
Large-stake holder rows connected to Schedule 13D/G evidence.
Rows
3
Security
ENVB
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| Ayrton Capital LLC | 10% | 658,465 | Ayrton Capital LLC | 30 Sep 2025 | ||||
| Lind Global Fund III LP | 7.9% | -21% | $314,402 | +$38,936 | 161,232 | +14% | EASTON JEFF | 31 Mar 2026 |
| INTRACOASTAL CAPITAL, LLC | 5% | 0% | $278,572 | +$155,982 | 71,246 | +127% | Mitchell P. Kopin | 27 Jan 2026 |
As of 31 Mar 2026, 11 institutional investors reported holding 54,976 shares of Enveric Biosciences, Inc. - Common Stock, $0.01 par value (ENVB). This represents 2.7% of the company’s total 2,048,691 outstanding shares.
Quarter history
Institutional holders across reporting periods
Holder count, reported shares/value, and median price by quarter.
Periods
2
Latest
Q1 2026
Rows shown
1-2 of 2